These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 3661039)

  • 1. Decreased gastrointestinal absorption of peroral polyethyleneglycols (PEG 1000) in Crohn's disease. A sign of jejunal abnormality.
    Olaison G; Sjödahl R; Tagesson C
    Acta Chir Scand; 1987; 153(5-6):373-7. PubMed ID: 3661039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered intestinal permeability to low-molecular-weight polyethyleneglycols (PEG 400) in patients with Crohn's disease.
    Magnusson KE; Sundqvist T; Sjödahl R; Tagesson C
    Acta Chir Scand; 1983; 149(3):323-7. PubMed ID: 6613469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Passage of molecules through the wall of the gastrointestinal tract. Intestinal permeability to polyethyleneglycol 1 000 in patients with Crohn's disease.
    Heuman R; Sjödahl R; Tagesson C
    Acta Chir Scand; 1982; 148(3):281-4. PubMed ID: 7136430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ineffectiveness of vitamin A therapy in severe Crohn's disease.
    Norrby S; Sjödahl R; Tagesson C
    Acta Chir Scand; 1985; 151(5):465-8. PubMed ID: 3901639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal permeability to polyethyleneglycol 600 in Crohn's disease. Peroperative determination in a defined segment of the small intestine.
    Olaison G; Leandersson P; Sjödahl R; Tagesson C
    Gut; 1988 Feb; 29(2):196-9. PubMed ID: 3345930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Jejunal Crohn's disease is associated with a higher postoperative recurrence rate than ileocaecal Crohn's disease.
    Keh C; Shatari T; Yamamoto T; Menon A; Clark MA; Keighley MR
    Colorectal Dis; 2005 Jul; 7(4):366-8. PubMed ID: 15932560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased intestinal permeability and NOD2 variants in familial and sporadic Crohn's disease.
    D'Incà R; Annese V; di Leo V; Latiano A; Quaino V; Abazia C; Vettorato MG; Sturniolo GC
    Aliment Pharmacol Ther; 2006 May; 23(10):1455-61. PubMed ID: 16669960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
    Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
    Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary report on the use of oral tacrolimus (FK506) in the treatment of complicated proximal small bowel and fistulizing Crohn's disease.
    Sandborn WJ
    Am J Gastroenterol; 1997 May; 92(5):876-9. PubMed ID: 9149205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal permeability is increased in a proportion of spouses of patients with Crohn's disease.
    Breslin NP; Nash C; Hilsden RJ; Hershfield NB; Price LM; Meddings JB; Sutherland LR
    Am J Gastroenterol; 2001 Oct; 96(10):2934-8. PubMed ID: 11693329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased gastric and intestinal permeability in patients with Crohn's disease.
    Wyatt J; Oberhuber G; Pongratz S; Püspök A; Moser G; Novacek G; Lochs H; Vogelsang H
    Am J Gastroenterol; 1997 Oct; 92(10):1891-6. PubMed ID: 9382060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary excretion of polyethylene glycol 3350 during colonoscopy preparation.
    Rothfuss KS; Bode JC; Stange EF; Parlesak A
    Z Gastroenterol; 2006 Feb; 44(2):167-72. PubMed ID: 16456758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MR of the small bowel with a biphasic oral contrast agent (polyethylene glycol): technical aspects and findings in patients affected by Crohn's disease.
    Laghi A; Paolantonio P; Iafrate F; Borrelli O; Dito L; Tomei E; Cucchiara S; Passariello R
    Radiol Med; 2003; 106(1-2):18-27. PubMed ID: 12951547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin B12 absorption after ileorectal anastomosis for Crohn's disease: effect of ileal resection and time span after surgery.
    Behrend C; Jeppesen PB; Mortensen PB
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):397-400. PubMed ID: 7614100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced local production of complement components in the small intestines of patients with Crohn's disease.
    Ahrenstedt O; Knutson L; Nilsson B; Nilsson-Ekdahl K; Odlind B; Hällgren R
    N Engl J Med; 1990 May; 322(19):1345-9. PubMed ID: 2325733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of moderate exercise on Crohn's disease patients in remission.
    D'Incà R; Varnier M; Mestriner C; Martines D; D'Odorico A; Sturniolo GC
    Ital J Gastroenterol Hepatol; 1999 Apr; 31(3):205-10. PubMed ID: 10379481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurements of intestinal permeability using low molecular weight polyethylene glycols (PEG 400). II. Application to normal and abnormal permeability states in man and animals.
    Chadwick VS; Phillips SF; Hofmann AF
    Gastroenterology; 1977 Aug; 73(2):247-51. PubMed ID: 873125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smoking and intestinal absorption of oral polyethylene glycols in Crohn's disease.
    Söderholm J; Olaison G; Sjödahl R; Tagesson C
    Scand J Gastroenterol; 1993 Feb; 28(2):163-7. PubMed ID: 8441909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for surgery and recurrence in 907 patients with primary ileocaecal Crohn's disease.
    Bernell O; Lapidus A; Hellers G
    Br J Surg; 2000 Dec; 87(12):1697-701. PubMed ID: 11122187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intestinal permeability in relatives of patients with Crohn's disease].
    Kohout P; Koref P
    Vnitr Lek; 2001 Jun; 47(6):371-4. PubMed ID: 11494882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.